ArticleOncotarget2016

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.

Nabil Amirouchene-Angelozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.